ARTICLE IN PRESS. Shin Matsuoka, Yasuyuki Kurihara, Kunihiro Yagihashi, Kyoko Okamoto, Hiroshi Niimi, Yasuo Nakajima
|
|
- Magnus Perry
- 5 years ago
- Views:
Transcription
1 Respiratory Medicine (2006) 100, Thin-section CT assessment of spontaneous pneumomediastinum in interstitial lung disease: Correlation with serial changes in lung parenchymal abnormalities $ Shin Matsuoka, Yasuyuki Kurihara, Kunihiro Yagihashi, Kyoko Okamoto, Hiroshi Niimi, Yasuo Nakajima Department of Radiology, St. Marianna University School of Medicine, Sugao, Miyamae-Ku, Kawasaki City, Kanagawa , Japan Received 10 February 2005; accepted 21 April 2005 KEYWORDS Pneumomedias tinum; Interstitial lung disease; Computed tomography Summary Purpose: The purpose of this study was to analyze thin-section computed tomography (CT) appearances of interstitial lung diseases before and at the time of detection of pneumomediastinum, and to evaluate the relationship between pneumomediastinum and parenchymal changes on thin-section CT. Materials & methods: We reviewed CT images before and at the time of detection of pneumomediastinum in 13 patients with idiopathic pulmonary fibrosis (8 patients) and collagen vascular diseases (5 patient). The extent of the total area of reticular opacity, increased opacity (ground-glass opacity and consolidation), and honeycombing were scored, and these scores were compared before and at the time of detection of pneumomediastinum. We also divided patients into two groups according to therapy received. Patients in group 1 experienced pneumomediastinum after or during treatment with corticosteroids or immunosuppressive agents for acute or subacute exacerbation of interstitial lung disease. Patients in group 2 experienced pneumomediastinum without therapy. Results: The mean score of all patients for honeycombing significantly increased at the time of detection of pneumomediastinum (P ¼ 0:003). In group 1, the extent of increasing opacity had been decreased significantly at the time of detection of pneumomediastinum (P ¼ 0:028). In group 2, the mean CT score of reticular opacity, $ The authors have no direct or indirect financial interest in the products under investigation or the subject matter discussed in this manuscript. Corresponding author. Tel.: ; fax: address: shinma@d9.dion.ne.jp (S. Matsuoka) /$ - see front matter & 2005 Elsevier Ltd. All rights reserved. doi: /j.rmed
2 12 S. Matsuoka et al. increasing opacity, and honeycombing significantly increased at the time of detection of pneumomediastinum (P ¼ 0:028, 0.018, and 0.018, respectively). Conclusions: Spontaneous pneumomediastinum associated with interstitial lung disease appears to have a tendency to occur under conditions of altered of parenchymal interstitial lesions. & 2005 Elsevier Ltd. All rights reserved. Introduction Spontaneous pneumomediastinum is an uncommon disorder that is usually benign and self-limiting. A variety of causes of pneumomediastinum have been described including mediastinal, pulmonary, chest wall, and even retroperitoneal pathologies resulting from trauma, infection, connective tissue disorder, assisted ventilation, and trivial routine life activity such as vigorous coughing, vomiting, or deep respiratory efforts Recently, researchers have reported that spontaneous pneumomediastinum occurred in patients with severe acute respiratory syndrome (SARS). 15,16 Spontaneous pneumomediastinum has been reported to be a rare complication of various types of interstitial lung disease, including idiopathic interstitial pneumonia 1 3 and connective tissue disorder. 4 8 However, previous series and case reports of pneumomediastinum associated with interstitial lung disease focused on precipitating factors, clinical presentation, and pathogenesis. To our knowledge, only one report has assessed computed tomography (CT) findings of lung parenchymal abnormalities in interstitial lung disease at the time of detection of pneumomediastinum. 2 The mechanism in which the pneumomediastinum arises in interstitial lung disease has not been clarified. The pathophysiology of pneumomediastinum was initially described by Macklin and Macklin 17 based on animal experiments. Pneumomediastinum could result from the rupture of distal pulmonary alveoli due to the rapid increase in intra-alveolar pressure in the alveoli, allowing air bubbles to travel along the vascular sheaths and connective tissue planes to the mediastinum. Considering this proposed mechanism, we hypothesized that some changes associated with the interstitial lung diseases would exist in the lung parenchyma at the onset of pneumomediastinum. The objective of our study was to analyze serial changes in CT appearances of interstitial lung diseases before and at the time of detection of pneumomediastinum and to evaluate the relationship between pneumomediastinum and changes in abnormal CT findings in interstitial lung diseases. Materials and methods Subjects We retrospectively reviewed the medical records and CT images of all patients with spontaneous pneumomediastinum who underwent CT between May 1999 and March Nineteen patients had an interstitial lung disease, including idiopathic interstitial pneumonia and collagen vascular disease. These indications of CT scan were routine follow-up of the interstitial lung disease or assessment of therapeutic effect. Idiopathic interstitial pneumonia included 10 idiopathic pulmonary fibrosis (IPF) and 2 non-specific interstitial pneumonia (NSIP). The diagnosis of IPF was based on the recent ATS/ ERS consensus statement on IPF, 18 or a clinicoradiographic presentation believed to be highly specific for IPF. 19 Two patient with NSIP was histologically diagnosed. We excluded 5 patients in whom chest CT was not done during the previous 6 months to the time of detection of pneumomediastinum, and 1 patient undergoing mechanical ventilation (2 patients, IPF; 2 patients, NSIP; and 2 patients, collagen vascular disease). The final study population consisted of 13 patients (8 men, 5 women; age range, years; mean age, years) with either IPF (8 patients) or collagen vascular disease (5 patients; dermatomyositis in 2 patients, mixed connective tissue disorder in 2 patients, and rheumatoid arthritis in 1 patient). Our Institutional Review Board did not require its approval or patient informed consent for this study. Thin-section CT scanning Thin-section CT scans were obtained with a variety of scanners. A total of 26 scans were performed on the 13 patients before and at the time of detection of pneumomediastinum. Seven scans in 6 patients were obtained using a multi-detector row spiral CT scanner (Aquillion or Asteion, Toshiba Medical, Tokyo, Japan) within one breath hold at deep inspiration. The scans were obtained with 4 2-mm collimation, with a table feed of mm per s scanner rotation. Scanning
3 Pneumomediastinum in interstitial lung disease 13 was performed at 120 kv and mas, using a matrix. Raw data were retrospectively reconstructed with a section thickness of 2-mm with 10-mm intervals using a lung algorithm. Nineteen scans in 11 patients were obtained with a single-detector helical CT scanner. Helical CT scans (X-Vigor, Toshiba Medical, Tokyo, Japan) were obtained throughout the entire thorax with 2-mm collimation with 8 10-mm intervals using a lung algorithm. Scanning parameters of helical CT were 120 kvp, mas, and 1-s scanning time. No intravenous contrast material was used. The lung window was set to a width of 1500 HU and a window level 650 HU. Evaluation of CT findings All thin-section CT images were reviewed retrospectively by two chest radiologists (Y.K. and S.M.). The CT scans before and at the time of detection of pneumomediastinum was evaluated in random order without knowledge of diagnosis, and the final assessment was achieved by consensus. CT analysis included presence and location of reticular opacity, ground-glass opacity, consolidation, and honeycombing. Ground-glass opacity was defined as areas showing a hazy increase of lung attenuation through which vessels could still be seen. Consolidation was considered present when the opacities obscured the underlying vessels. Honeycombing was defined as end-stage lung damage, which was manifested as multiple thin-wall cysts. 20 The anatomic distribution was noted to be central if there was a predominance of abnormalities in the inner third of the transverse plane, and peripheral if there was a predominance of abnormalities in the outer third of the transverse plane. If abnormalities were seen along the bronchovascular bundle, the distribution was regarded as peribronchial. If the abnormality had no prediction, it was regarded as random distribution. In the craniocaudal direction, zonal predominance was assessed as upper, or lower. Upper lung zonal predominance was considered present when most of the abnormalities were above the level of the tracheal carina, and lower lung zonal predominance was considered present when most of the abnormalities were below this level. Observers then visually scored (to the nearest 5%) the total extent of abnormal parenchyma at four preselected levels: (a) upper: aortic arch; (b) middle: carina; (c) lower: between b and d; and (d) bottom: 1 cm above the dome of the right hemidiaphragm. The extent of involvement of each abnormality was assessed independently for each of the 4 zones of each lung. The CT scan score was calculated by multiplying the percentage of ground-glass opacity, consolidation, and honeycombing in each zone by a factor that corrected for differences in volume between the zones. The ratio of the volumes of the upper, middle, and lower (lower and bottom) lung zones was estimated as 1:1.6:1.3, based on previously published data. 21 We also assessed the extent of the lung involved with increasing opacity including ground-glass opacity and consolidation. CT scan scores were compared before and at the detection of pneumomediastinum. We also divided patients into two groups according to whether therapy with corticosteroid or immunosuppressive agents for acute or subacute exacerbation of interstitial lung disease was given. Group 1 (n ¼ 6, age: years; mean: 61.7 years) consisted of patients in whom pneumomediastinum occurred after or during treatment with corticosteroids or immunosuppressive agents for acute or subacute exacerbation of interstitial lung disease. Group 2 (n ¼ 7, age: years; mean: 71.0 years) consisted of stable without evidence of exacerbation of interstitial lung disease who did not receive corticosteroids or immunosuppressive agents but who developed pneumomediastinum. Statistical analysis All statistical analyses were performed using JMP software (SAS Institute, Cary, NC). Data are expressed as mean7standard deviation. Comparisons of each CT scan score before and at the detection of pneumomediastinum were performed using the Wilcoxon single rank test. For all statistical analyses, a P-value less than 0.05 was considered significant. Results The characteristics and clinical findings of each patient are shown in Table 1. Two patient had mild dyspnea, and two patients presented with moderate cough at the time of detection of pneumomediastinum. The remaining nine patients had no respiratory symptom. None of the patients had been intubated or biopsied close to the time of detection of pneumomediastinum. The mean observation period or CT interval between before and at the detection of pneumomediastinum was 79.6 days (50.5 days in group 1 and, days in group 2).
4 14 S. Matsuoka et al. Table 1 The patients characteristics and clinical findings. Patient number Sex Age Diagnosis Observation period Physical symptoms Therapy for exacerbation Group 1 with therapy Group 2 without therapy 1 M 91 IPF 27 Cough, Steroid pulse dyspnea 2 F 28 DM 93 Non Steroid, immunosuppressive agents 3 F 63 MCTD 13 Non Steroid pulse 4 M 86 IPF 15 Cough Steroid pulse 5 M 73 IPF 95 Non Steroid pulse 6 M 29 MCTD 20 Non Steroid, immunosuppressive agents 7 M 72 IPF 120 Non 8 F 66 DM 42 Non 9 F 80 IPF 160 Non 10 F 69 IPF 35 Non 11 M 68 IPF 135 Non 12 M 74 Rheumatoid 98 Non arthritis 13 M 68 IPF 142 Dyspnea Note: IPF: idiopathic pulmonary fibrosis, DM: dermatomyositis, MCTD: mixed connective-tissue disease. Table 2 The abnormal CT findings before and at the detection of pneumomediastinum. Before pneumomediastinum At detection pneumomediastinum Cases Extent (%) Cases Extent (%) Group 1 (n ¼ 6) Reticular opacity 6 (100) 11 6 (100) 9 Ground-glass Opacity 6 (100) 23 6 (100) 10 Consolidation 6 (100) 13 4 (67) 5 Honeycombing 4 (67) 6 4 (67) 9 Group 2 (n ¼ 7) Reticular Opacity 7 (100) 10 7 (100) 15 Ground-glass opacity 5 (71) 8 7 (100) 14 Consolidation 6 (86) 3 7 (100) 7 Honeycombing 6 (86) 11 7 (100) 17 Note: Numbers in parentheses are percentages. The presence and predominant location of each CT finding are summarized in Table 2. At the time of detection of pneumomediastinum, CT scans revealed reticular opacity in 13 patients, groundglass opacity in 13 patients, consolidation in 11 patients, and honeycombing in 11 patients. Reticular opacity predominated in the lower lung zone in 6 patients but was evenly distributed in all zones of 7 patients, and at the lung periphery in 8 patients. Ground-glass opacity predominated in the lower lung zone in 8 patients, and at the lung periphery in 7 patients. Consolidation predominated in the lower lung zone in 7 patients, and at the lung periphery in 6 patients. Honeycombing predominated in the lower lung zone and at the lung periphery in all patients. The mean score for all patients for reticular opacity was before pneumomediastinum and at the time of detection of pneumomediastinum. For all patients, no significant differences were seen in scores before and at the time of detection of pneumomediastinum (P ¼ 0:22). In group 1, no significant difference was found in scores before and at the time of pneumomediastinum ( vs , respectively; P ¼ 0:17). However, in group 2, the mean score for reticular opacity was significantly lower before pneumomediastinum compared with at the time of
5 Pneumomediastinum in interstitial lung disease 15 detection of pneumomediastinum ( vs , respectively; P ¼ 0:028). The mean score for all patients for ground-glass opacity was before pneumomediastinum and at the time of detection of pneumomediastinum. For all patients, no significant differences were seen in scores before and at the time of detection of pneumomediastinum (P ¼ 0:51). However, when patients were divided into groups, significant differences were seen before and at the time of detection of pneumomediastinum. In group 1, the mean score for groundglass opacity was significantly higher before detection of pneumomediastinum than at the time of detection of pneumomediastinum ( vs , respectively; P ¼ 0:028) (Fig. 1). In contrast, in group 2, the mean score for groundglass opacity was significantly lower before pneumomediastinum compared with at the time of detection of pneumomediastinum ( vs , respectively; P ¼ 0:018). The mean consolidation score for all patients was before pneumomediastinum and at the time of detection of pneumomediastinum. For all patients, no significant difference was found between before and at the time of detection of pneumomediastinum (P ¼ 0:75). Again, group differences were seen. In group 1, the mean score for consolidation was significantly higher before pneumomediastinum than at the time of detection of pneumomediastinum ( vs , respectively; P ¼ 0:028). In contrast, in group 2, the mean score for consolidation was significantly lower before pneumomediastinum than at the time of detection of pneumomediastinum ( vs , respectively; P ¼ 0:018). The mean score of all patients for increasing opacity was before pneumomediastinum and at the time of detection of pneumomediastinum (p ¼ 0:42). In group 1, The mean CT score of increasing opacity significantly decreased at the time of detection of pneumomediastinum ( vs , respectively; P ¼ 0:028) (Fig. 2), and in group 2, the mean CT score of increasing opacity significantly increased at the time of detection of pneumomediastinum ( vs , respectively; P ¼ 0:018) (Fig. 2). The mean score of all patients for honeycombing increased significantly from before pneumomediastinum to at the time of detection of pneumomediastinum (P ¼ 0:003) (Fig. 3). When divided into groups, honeycombing scores before and at the time of detection of pneumomediastinum were no longer significant in group 1 ( vs ; P ¼ 0:068) (Fig. 4). However, in group 2, the mean CT score of honeycombing was significantly increased at the time of detection of pneumomediastinum ( before pneumomediastinum vs at the time of detection of pneumomediastinum, P ¼ 0:018) (Fig. 4). Discussion Figure 1 Images in 86-year-old man with exacerbation of idiopathic pulmonary fibrosis. Transverse thin-section CT shows that ground-glass opacity (white arrowhead) has been decreased at the detection of pneumomediastinum (b) as compared with before CT scan (a). In this study, we found that the extent of increasing opacity, including ground-glass opacity and consolidation decreased at the detection of pneumomediastinum associated with interstitial lung disease which had been treated with corticosteroids or immunosuppressive agents for exacerbation of interstitial lung disease. In stable patients those who had not received treatment with
6 16 S. Matsuoka et al Extent of Increased Opacity (%) (a) 0 45 Before Pneumomediastinum Extent of Increased Opacity (%) (b) Before Pneumomediastinum Figure 2 Change of CT scores for increased lung opacity before and at the detection of pneumomediastinum. (a) In group 1, the extent of increasing opacity had been decreased significantly at the time of detection of pneumomediastinum (P ¼ 0:028). (b) In group 2, the mean CT score of increasing opacity was significantly increased at the time of detection of pneumomediastinum (P ¼ 0:018). Figure 3 Transverse thin-section CT scans in 72-year-old man with idiopathic pulmonary fibrosis without therapy. The extent of honeycombing (white arrowhead) has been increased at the detection of pneumomediastinum (b) as compared with before CT scan (a). corticosteroids or immunosuppressive agents, there was an increase in the extent of reticular opacity, increasing opacity, and honeycombing at the detection of pneumomediastinum. Thus, spontaneous pneumomediastinum associated with interstitial lung disease appears to have a tendency to occur under conditions of altered of parenchymal lesions. Though we cannot explain the correlation between the occurrence of pneumomediastinum and altered parenchymal lesions in interstitial lung diseases, some speculation is possible. Spontaneous pneumomediastinum is thought to begin with a rapid increase in intra-alveolar pressure, air leaks from the ruptured alveoli and accumulates along the bronchovascular sheath. 17 The basic requirement for alveolar rupture is the existence of a pressure gradient between the alveolus and its surrounding structure. The pressure within the adjacent alveoli is generally assumed to be equal, so the intra-alveolar wall should remain intact. However, when intra-alveolar pressure increases or perivascular interstitial pressure decreases, a gradient is created. In our study, the
7 Pneumomediastinum in interstitial lung disease 17 Extent of Honeycombing (%) (a) Extent of Honeycombing (%) (b) Before Before Pneumomodiastinum Pneumomodiastinum Figure 4 Change of CTscores for extent of honeycombing before and at the detection of pneumomediastinum. (a) In group 1, no significant difference was found between before and at the detection of pneumomediastinum (P ¼ 0:068). (b) In group 2, the difference was significant (P ¼ 0:018) by Wilcoxon signed rank test. extent of ground-glass opacity and consolidation was decreased at the detection of pneumomediastinum in patients who had received corticosteroids or immunosuppresive therapy for exacerbation of interstitial lung disease. These patients showed various degrees of improvement following drug therapy. In patients with deterioration of idiopathic pulmonary fibrosis, ground-glass opacity has been shown to correspond pathologically with acute diffuse alveolar damage or active fibroblastic foci. 22 In these circumstances, alveolar collapse occurs as a result of structural changes, reduced compliance, or obliteration of alveoli. Re-expansion of the alveolus as a result of reacting to drug treatment might increase intra-alveolus pressure. Thus, pneumomediastinum may occur under such circumstances in conjunction with the existence of a damaged alveolar wall. In addition, heterogeneous or partial fibrosis might produce an area of uneven alveolar expansion in which disproportionate alveolar pressure occurs between alveoli. It is assumed there is an increased risk of rupture in the hyperinflated alveolus. In contrast, though the mechanism of action of corticosteroid therapy for the acute exacerbation of interstitial pneumonia has not been sufficiently clarified, Yamanishi et al. 23 suggested that the weakening effects of corticosteroids on the interstitial tissues of the lungs might cause pneumomediastinum. In a literature review of 13 cases of dermatomyositis, pneumomediastinum occurred during steroid treatment in all but 1 paient. 4 Therefore, the relation of pneumomediastinum generation and steroid therapy must be considered. Honeycomb cysts usually enlarge slowly over time. 24 In patients with usual interstitial pneumonia, more active inflammation of the pulmonary interstitium results in faster progression of honeycombing over long-term follow-up. 25 In our patients without evidence of exacerbation of interstitial lung disease at the detection of pneumomediastinum, the extent of reticular opacity, increasing opacity, and honeycombing was increased at the detection of pneumomediastinum. Therefore, it is possible that active inflammation existed in the period between before and at the time of pneumomediastinum, and that fibrosis may have progressed asymptomatically. Increases in the air cystic space as a result of activity of the interstitial pneumonia and fibrosis may increase the risk for pneumomediastinum. The association between pneumomediastinum and interstitial lung disease has been mentioned in several articles. 1 3 Franquet et al. 2 found spontaneous pneumomediastinum in 4 patients of 78 patients (5.1%) with idiopathic pulmonary fibrosis. They assessed the presence and distribution of pulmonary parenchymal abnormalities on CT images at the time of detection of
8 18 pneumomediastinum, and found that parenchymal abnormalities such as ground-glass attenuation or honeycombing showed a subpleural predominance. In a study of 34 patients with interstitial pulmonary fibrosis, Fujiwara 1 identified pneumomediastinum on chest CT scans in 5 patients (14.7%). However, they did not assess parenchymal abnormalities at the onset of pneumomediastinum, and assumed that honeycombing and violent cough were predisposing factors for pneumomediastinum. In our patients, the mean score for honeycombing significantly increased at the time of detection of pneumomediastinum, however, there was no patients with prominent clinical symptoms such as violent cough. O Connor and Thomas. 3 described a case of pneumomediastinum in a patient with fibrosing alveolitis. Fibrosing alveolitis produces area of uneven lung expansion, with hyperinflation and areas of atelectasis. This author assumed there was an increased risk of rupture in the hyperinflated areas of the lung. However, in these previous reports, the mechanism in which the pneumomediastinum arises in patients with interstitial pneumonia was not clarified. On the other hand, Ichikawa et al. 9 reported a case of a patient in whom pneumomediastinum occurred in association with hypersensitive pneumonitis, and on lung biopsy, overdistention or disruption of alveoli with obliteration of the respiratory bronchioles was revealed. They speculated that increased intraalveolar pressure occurring as a result of check valve bronchiolar obstruction induced pneumomediastinum. In contrast, Kono et al. 4 assessed pneumomediastinum in dermatomyosistis associated with cutaneous vasculopathy in 17 patients; they found that 14 patients had interstitial pneumonia and 3 did not. Hence, the cause of pneumomediastinum was assumed to be necrosis of the bronchial wall due to vasculopathy, and they concluded that pneumomediastinum is associated not with interstitial pneumonia but with cutaneous vasculopathy. Santiago et al. 6 reported on the occurrence of pneumomediastinum and interstitial lung disease in dermatomyosistis without vasculopathy. Cutaneous vasculopathy was not confirmed in our patients. Thus, the role of vasculitis as pathogenic mechanism of pneumomediastinum in dermatomyositis has been controversial. In one study, a substantial proportion (12%) of patient with SARS developed spontaneous pneumomediastinum unrelated to the use of positive endexpiratory pressure ventilation. 15 This occurred most commonly as the ground-glass opacities and consolidations began to resolve. Autopsies in patients with SARS showed diffuse alveolar damage S. Matsuoka et al. in varying phases of organization. 26,27 In our patients who had received steroid therapy, pneumomediastinum occurred in a similar fashion. Thus, the mechanism of developing pneumomediastinum associated with SARS might arise by the similar mechanism in interstitial lung disease. Spontaneous pneumothorax also has been reported to be a rare complication of idiopathic interstitial pneumonia. 28,29 In our study, there was no case that pneumomediastinum associated with pneumothorax was seen. Similarly, Franquet et al. 2 found spontaneous pneumothorax without pneumomediastinum in 5 patients of 78 patients (6.4%) with IPF. The mechanism of developing pneumothorax may be different from pneumomediastinum. Further investigation is required. The present study has several limitations. First, there were few pathological diagnoses of interstitial lung disease, because most patients showed comparatively typical CT findings and clinical courses of their respective interstitial lung disease, thus pathological examinations were not required. Second, there was unequable in the period between before and at the onset of pneumomediastinum. Pneumomediastinum might occur before the time of detection on CT scan. Third, the present sample numbers were small for evaluation of differences among various histological types or between idiopathic interstitial pneumonia and collagen vascular disease. Those differences might affect the results. Fourth, there is the possibility by except for interstitial pneumonia on cause of pneumomediastinum. Pneumomediastinum is also generated by violent cough or pulmonary function test. 30 However, our patients had not suffered from violent cough, and there was no case of pneumomediastinum generation for a few days after pulmonary function test. In conclusion, we found that development of pneumomediastinum in association with interstitial lung disease is correlated with the alteration of abnormalities in lung parenchyma. Most patients had no clinical symptom such as violent cough at the detection of pneumomediastinum, hence the changes of lung abnormalities probably causes an increase in intra-alveolar pressure. When pneumomediastinum occurs in patients receiving therapy with corticosteroids or immunosuppressive agents for acute or subacute exacerbation of interstitial lung disease, increasing opacities, which indicate disease activity, have been shown to decrease. Conversely, when pneumomediastinum occurs in patients who did not receive corticosteroids or immunosuppressive agents, the progress of interstitial fibrosis should be considered.
9 Pneumomediastinum in interstitial lung disease 19 References 1. Fujiwara T. Pneumomediastinum in pulmonary fibrosis. Detection by computed tomography. Chest 1993;104: Franquet T, Gimenez A, Torrubia S, Sabate JM, Rodriguez- Arias JM. Spontaneous pneumothorax and pneumomediastinum in IPF. Eur Radiol 2000;10: O Connor I, Thomas GO. Spontaneous pneumomediastinum in a patient with fibrosing alveolitis. Respir Med 1993;87: Kono H, Inokuma S, Nakayama H, Suzuki M. Pneumomediastinum in dermatomyositis: association with cutaneous vasculopathy. Ann Rheum Dis 2000;59: Nagai Y, Ishikawa O, Miyachi Y. Pneumomediastinum and subcutaneous emphysema associated with fatal interstitial pneumonia in dermatomyositis. J Dermatol 1997;24: Santiago MB, Chalhoub M, Pereira ST. Amyopathic dermatomyositis complicated by interstitial pulmonary disease and pneumomediastinum. J Rheumatol 1998;25: Bradley JD. Spontaneous pneumomediastinum in adult dermatomyositis. Ann Rheum Dis 1986;45: Patel A, Kesler B, Wise RA. Persistent pneumomediastinum in interstitial fibrosis associated with rheumatoid arthritis: treatment with high-concentration oxygen. Chest 2000;117: Ichikawa Y, Tokunaga N, Kinoshita M, Rikimaru T, Kaji M. Subcutaneous and mediastinal emphysema associated with hypersensitivity pneumonitis. Chest 1991;99: Varkey B, Kory RC. Mediastinal and subcutaneous emphysema following pulmonary function tests. Am Rev Respir Dis 1973;108: Sikdar T, MacVicar D, Husband JE. Pneumomediastinum complicating bleomycin related lung damage. Br J Radiol 1998;71: Kirsh MM, Orvald TO. Mediastinal and subcutaneous emphysema complicating acute bronchial asthma. Chest 1970;57: Jougon JB, Ballester M, Delcambre F, Mac Bride T, Dromer CE, Velly JF. Assessment of spontaneous pneumomediastinum: experience with 12 patients. Ann Thorac Surg 2003;75: Abolnik I, Lossos IS, Breuer R. Spontaneous pneumomediastinum. A report of 25 cases. Chest 1991;100: Peiris JS, Chu CM, Cheng VC, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003;361: Ooi GC, Khong PL, Muller NL, et al. Severe acute respiratory syndrome: temporal lung changes at thin-section CT in 30 patients. Radiology 2004;230: Macklin MT, Macklin CC. Malignant interstitial emphysema of the lungs and mediastinum as an important occult complication in many respiratory diseases and other conditions: an interpretation of the clinical literature in the light of laboratory experiment. Medicine 1944;23: American Thoracic Society, Idiopathic pulmonary fibrosis: diagnosis and treatment; international consensus statement. American Thoracic Society (ATS), the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000;161: Hunninghake GW, Zimmerman MB, Schwartz DA, et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001;164: Austin JH, Muller NL, Friedman PJ, et al. Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society. Radiology 1996; 200: Muller NL, Mawson JB, Mathieson JR, Abboud R, Ostrow DN, Champion P. Sarcoidosis: correlation of extent of disease at CT with clinical, functional, and radiographic findings. Radiology 1989;171: Akira M, Hamada H, Sakatani M, Kobayashi C, Nishioka M, Yamamoto S. CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. Am J Roentgenol 1997;168: Yamanishi Y, Maeda H, Konishi F, et al. Dermatomyositis associated with rapidly progressive fatal interstitial pneumonitis and pneumomediastinum. Scand J Rheumatol 1999;28: Akira M, Sakatani M, Ueda E. Idiopathic pulmonary fibrosis: progression of honeycombing at thin-section CT. Radiology 1993;189: Lee JS, Gong G, Song KS, Kim DS, Lim TH. Usual interstitial pneumonia: relationship between disease activity and the progression of honeycombing at thin-section computed tomography. J Thorac Imaging 1998;13: Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003;348: Nicholls JM, Poon LL, Lee KC, et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet 2003;361: McLoud TC, Carrington CB, Gaensler EA. Diffuse infiltrative lung disease: a new scheme for description. Radiology 1983;149: Picado C, Gomez de Almeida R, Xaubet A, Montserrat J, Letang E, Sanchez-Lloret J. Spontaneous pneumothorax in cryptogenic fibrosing alveolitis. Respiration 1985;48: Varkey B, Kory RC. Mediastinal and subcutaneous emphysema following pulmonary function tests. Am Rev Respir Dis 1973;108:
Key words: CT scanners; interstitial lung diseases; polymyositis-dermatomyositis; x-ray
Nonspecific Interstitial Pneumonia Associated With Polymyositis and Dermatomyositis* Serial High-Resolution CT Findings and Functional Correlation Hiroaki Arakawa, MD; Hidehiro Yamada, MD; Yasuyuki Kurihara,
More informationHRCT in Diffuse Interstitial Lung Disease Steps in High Resolution CT Diagnosis. Where are the lymphatics? Anatomic distribution
Steps in High Resolution CT Diagnosis Pattern of abnormality Distribution of disease Associated findings Clinical history Tomás Franquet MD What is the diagnosis? Hospital de Sant Pau. Barcelona Secondary
More information5/9/2015. Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective. No, I am not a pulmonologist! Radiology
Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective No, I am not a pulmonologist! Radiology Pathology Clinical 1 Everyone needs a CT Confidence in diagnosis Definitive HRCT +
More information11/10/2014. Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective. Radiology
Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective Radiology Pathology Clinical 1 Role of HRCT Diagnosis Fibrosis vs. inflammation Next step in management Response to treatment
More informationNONE OVERVIEW FINANCIAL DISCLOSURES UPDATE ON IDIOPATHIC PULMONARY FIBROSIS/IPF (UIP) FOR PATHOLOGISTS. IPF = Idiopathic UIP Radiologic UIP Path UIP
UPDATE ON IDIOPATHIC PULMONARY FIBROSIS/IPF () FOR PATHOLOGISTS Thomas V. Colby, M.D. Professor of Pathology (Emeritus) Mayo Clinic Arizona FINANCIAL DISCLOSURES NONE OVERVIEW IPF Radiologic Dx Pathologic
More informationUsual Interstitial pneumonia and Nonspecific Interstitial Pneumonia. Nitra and the Gangs.
Usual Interstitial pneumonia and Nonspecific Interstitial Pneumonia Nitra and the Gangs. บทน ำและบทท ๓, ๑๐, ๑๒, ๑๓, ๑๔, ๑๕, ๑๗ Usual Interstitial Pneumonia (UIP) Most common & basic pathologic pattern
More informationCryptogenic Organizing Pneumonia: Serial High-Resolution CT Findings in 22 Patients
Cardiopulmonary Imaging Original Research Lee et al. High-Resolution CT of Cryptogenic Organizing Pneumonia Cardiopulmonary Imaging Original Research Ju Won Lee 1 Kyung Soo Lee 1 Ho Yun Lee 1 Man Pyo Chung
More informationDifferential diagnosis
Differential diagnosis Idiopathic pulmonary fibrosis (IPF) is part of a large family of idiopathic interstitial pneumonias (IIP), one of four subgroups of interstitial lung disease (ILD). Differential
More informationProgress in Idiopathic Pulmonary Fibrosis
Progress in Idiopathic Pulmonary Fibrosis David A. Lynch, MB Disclosures Progress in Idiopathic Pulmonary Fibrosis David A Lynch, MB Consultant: t Research support: Perceptive Imaging Boehringer Ingelheim
More informationEarly View Article: Online published version of an accepted article before publication in the final form.
: Online published version of an accepted article before publication in the final form. Journal Name: International Journal of Case Reports and Images (IJCRI) Type of Article: Clinical Images Title: Successful
More informationCryptogenic Organizing Pneumonia Diagnosis Approach Based on a Clinical-Radiologic-Pathologic Consensus
Cryptogenic Organizing Pneumonia Diagnosis Approach Based on a Clinical-Radiologic-Pathologic Consensus Poster No.: C-1622 Congress: ECR 2012 Type: Scientific Exhibit Authors: C. Cordero Lares, E. Zorita
More informationNon-neoplastic Lung Disease II
Pathobasic Non-neoplastic Lung Disease II Spasenija Savic Prince Pathology Program Systematic approach to surgical lung biopsies with ILD Examples (chronic ILD): Idiopathic interstitial pneumonias: UIP,
More informationThe Egyptian Journal of Hospital Medicine (July 2017) Vol.68 (2), Page
The Egyptian Journal of Hospital Medicine (July 2017) Vol.68 (2), Page 1135-1140 Role of High Resolution Computed Tomography in Diagnosis of Interstitial Lung Diseases in Patients with Collagen Diseases
More informationLiebow and Carrington's original classification of IIP
Liebow and Carrington's original classification of IIP-- 1969 Eric J. Stern MD University of Washington UIP Usual interstitial pneumonia DIP Desquamative interstitial pneumonia BIP Bronchiolitis obliterans
More informationThoracic lung involvement in rheumatoid arthritis: Findings on HRCT
Thoracic lung involvement in rheumatoid arthritis: Findings on HRCT Poster No.: C-2488 Congress: ECR 2015 Type: Educational Exhibit Authors: R. E. Correa Soto, M. J. Martín Sánchez, J. M. Fernandez 1 1
More informationPediatric High-Resolution Chest CT
Pediatric High-Resolution Chest CT Alan S. Brody, MD Professor of Radiology and Pediatrics Chief, Thoracic Imaging Cincinnati Children s s Hospital Cincinnati, Ohio, USA Pediatric High-Resolution CT Short
More informationCTD-related Lung Disease
13 th Cambridge Chest Meeting King s College, Cambridge April 2015 Imaging of CTD-related Lung Disease Dr Sujal R Desai King s College Hospital, London Disclosure Statement No Disclosures / Conflicts of
More informationFinancial disclosure COMMON DIAGNOSES IN HRCT. High Res Chest HRCT. HRCT Pre test. I have no financial relationships to disclose. Anatomy Nomenclature
Financial disclosure I have no financial relationships to disclose. Douglas Johnson D.O. Cardiothoracic Imaging Gaston Radiology COMMON DIAGNOSES IN HRCT High Res Chest Anatomy Nomenclature HRCT Sampling
More informationT he diagnostic evaluation of a patient with
546 REVIEW SERIES Challenges in pulmonary fibrosis? 1: Use of high resolution CT scanning of the lung for the evaluation of patients with idiopathic interstitial pneumonias Michael B Gotway, Michelle M
More informationRestrictive lung diseases
Restrictive lung diseases Restrictive lung diseases are diseases that affect the interstitium of the lung. Interstitium of the lung is the very thin walls surrounding the alveoli, it s formed of epithelium
More informationOutline Definition of Terms: Lexicon. Traction Bronchiectasis
HRCT OF IDIOPATHIC INTERSTITIAL PNEUMONIAS Disclosures Genentech, Inc. Speakers Bureau Tadashi Allen, MD University of Minnesota Assistant Professor Diagnostic Radiology 10/29/2016 Outline Definition of
More informationCriteria for confident HRCT diagnosis of usual interstitial pneumonia (UIP)
Criteria for confident HRCT diagnosis of usual interstitial pneumonia (UIP) Assem El Essawy (1) & Amr A. Nassef (٢) Abstract Identification of interstitial pneumonia (IP) was mainly based on histological
More informationSystemic lupus erythematosus (SLE): Pleuropulmonary Manifestations
08/30/10 09/26/10 Systemic lupus erythematosus (SLE): Pleuropulmonary Manifestations Camila Downey S. Universidad de Chile, School of Medicine, Year VII Harvard University, School of Medicine Sept 17,
More informationDiffuse Interstitial Lung Diseases: Is There Really Anything New?
: Is There Really Anything New? Sujal R. Desai, MBBS, MD ESTI SPEAKER SUNDAY Society of Thoracic Radiology San Antonio, Texas March 2014 Diffuse Interstitial Lung Disease The State of Play DILDs Is There
More informationPulmonary And Central Nervous System Involvement In Juvenile Dermatomyositis: Vasculopathy And/Or Steroids As Causative Agents - A Case Report
ISPUB.COM The Internet Journal of Radiology Volume 4 Number 1 Pulmonary And Central Nervous System Involvement In Juvenile Dermatomyositis: Vasculopathy And/Or Steroids As Causative Agents - A Case Report
More informationDiagnosing Idiopathic Pulmonary Fibrosis on Evidence-Based Guidelines
Diagnosing Idiopathic Pulmonary Fibrosis on Evidence-Based Guidelines Rebecca Keith, MD Assistant Professor, Division of Pulmonary and Critical Care Medicine National Jewish Health, Denver, CO Objectives
More informationINTERSTITIAL LUNG DISEASE. Radhika Reddy MD Pulmonary/Critical Care Long Beach VA Medical Center January 5, 2018
INTERSTITIAL LUNG DISEASE Radhika Reddy MD Pulmonary/Critical Care Long Beach VA Medical Center January 5, 2018 Interstitial Lung Disease Interstitial Lung Disease Prevalence by Diagnosis: Idiopathic Interstitial
More informationImaging: how to recognise idiopathic pulmonary fibrosis
REVIEW IDIOPATHIC PULMONARY FIBROSIS Imaging: how to recognise idiopathic pulmonary fibrosis Anand Devaraj Affiliations: Dept of Radiology, St George s Hospital, London, UK. Correspondence: Anand Devaraj,
More informationAn Image Repository for Chest CT
An Image Repository for Chest CT Francesco Frajoli for the Chest CT in Antibody Deficiency Group An Image Repository for Chest CT he Chest CT in Antibody Deficiency Group is an international and interdisciplinary
More information4/16/2017. Learning Objectives. Interpretation of the Chest Radiograph. Components. Production of the Radiograph. Density & Appearance
Interpretation of the Arthur Jones, EdD, RRT Learning Objectives Identify technical defects in chest radiographs Identify common radiographic abnormalities This Presentation is Approved for 1 CRCE Credit
More informationConnective Tissue Disorder- Associated Interstitial Lung Disease (CTD-ILD) and Updates
Connective Tissue Disorder- Associated Interstitial Lung Disease (CTD-ILD) and Updates Maria Elena Vega, M.D Assistant Professor of Medicine Lewis Katz School of Medicine at Temple University Nothing to
More informationPulmonary fibrosis on the lateral chest radiograph: Kerley D lines revisited
Insights Imaging (2017) 8:483 489 DOI 10.1007/s13244-017-0565-2 PICTORIAL REVIEW Pulmonary fibrosis on the lateral chest radiograph: Kerley D lines revisited Daniel B. Green 1 & Alan C. Legasto 1 & Ian
More informationCase Report pissn / eissn J Korean Soc Radiol 2016;75(2):
Case Report pissn 1738-2637 / eissn 2288-2928 http://dx.doi.org/10.3348/jksr.2016.75.2.151 Thoracic Air-Leakage Syndrome in Allogeneic Stem Cell Transplant Recipients as a Late Complication of Chronic
More informationThin-Section CT Findings in 32 Immunocompromised Patients with Cytomegalovirus Pneumonia Who Do Not Have AIDS
Tomás Franquet 1,2 Kyung S. Lee 3 Nestor L. Müller 1 Received January 27, 2003; accepted after revision April 21, 2003. 1 Department of Radiology, Vancouver Hospital and Health Sciences Center and University
More informationSuccessful treatment of pneumomediastinum in a patient with interstitial lung disease due to anti-synthetase syndrome: A case report
www.edoriumjournals.com CLINICAL IMAGE PEER REVIEWED OPEN ACCESS Successful treatment of pneumomediastinum in a patient with interstitial lung disease due to anti-synthetase syndrome: A case report Roy
More informationAcute and Chronic Lung Disease
KATHOLIEKE UNIVERSITEIT LEUVEN Faculty of Medicine Acute and Chronic Lung Disease W De Wever, JA Verschakelen Department of Radiology, University Hospitals Leuven, Belgium Clinical utility of HRCT To detect
More informationMonday 10 September Interstitial lung disease 15:10 15:35. The uncommon interstitial lung diseases (ILD)
Interstitial lung disease 15:10 15:35 The uncommon interstitial lung diseases (ILD) Dr Grant Griffiths, Cwm Taf University Health Board, Cardiff Be familiar with the Diagnostic criteria for idiopathic
More informationCombined Unclassifiable Interstitial Pneumonia and Emphysema: A Report of Two Cases
CASE REPORT Combined Unclassifiable Interstitial Pneumonia and Emphysema: A Report of Two Cases Nobuhiko Nagata 1, Kentaro Watanabe 2, Michihiro Yoshimi 3, Hiroshi Okabayashi 4, Katsuo Sueishi 5, Kentaro
More informationIdiopathic interstitial pneumonias (IIPs) are a group of
SYMPOSIA C. Isabela S. Silva, MD, PhD and Nestor L. Müller, MD, PhD Abstract: The idiopathic interstitial pneumonias (IIPs) are a group of diffuse parenchymal lung diseases of unknown etiology characterized
More informationEun-Young Kang, M.D., Jae Wook Lee, M.D., Ji Yung Choo, M.D., Hwan Seok Yong, M.D., Ki Yeol Lee, M.D., Yu-Whan Oh, M.D.
Eun-Young Kang, M.D., Jae Wook Lee, M.D., Ji Yung Choo, M.D., Hwan Seok Yong, M.D., Ki Yeol Lee, M.D., Yu-Whan Oh, M.D. Department of Radiology, Korea University Guro Hospital, College of Medicine, Korea
More informationPulmonary manifestations of CTDs Diagnosis, differential diagnosis and treatment
Prague, June 2014 Pulmonary manifestations of CTDs Diagnosis, differential diagnosis and treatment Katerina M. Antoniou, MD, PhD As. Professor in Thoracic Medicine ERS ILD Group Secretary Medical School,
More informationTB Radiology for Nurses Garold O. Minns, MD
TB Nurse Case Management Salina, Kansas March 31-April 1, 2010 TB Radiology for Nurses Garold O. Minns, MD April 1, 2010 TB Radiology for Nurses Highway Patrol Training Center Salina, KS April 1, 2010
More informationSerial computed tomographic evaluation in desquamative interstitial pneumonia
Thorax 1997;52:333 337 333 Serial computed tomographic evaluation in desquamative interstitial pneumonia Masanori Akira, Satoru Yamamoto, Hideki Hara, Mitsunori Sakatani, Einosuke Ueda Abstract a better
More informationARTICLE IN PRESS. Ahuva Grubstein a, Daniele Bendayan b, Ithak Schactman c, Maya Cohen a, David Shitrit b, Mordechai R. Kramer b,
Respiratory Medicine (2005) 99, 948 954 Concomitant upper-lobe bullous emphysema, lower-lobe interstitial fibrosis and pulmonary hypertension in heavy smokers: report of eight cases and review of the literature
More information4/17/2010 C ini n ca c l a Ev E a v l a ua u t a ion o n of o ILD U dat a e t e i n I LDs
Update in ILDs Diagnosis 101: Clinical Evaluation April 17, 2010 Jay H. Ryu, MD Mayo Clinic, Rochester MN Clinical Evaluation of ILD Outline General aspects of ILDs Classification of ILDs Clinical evaluation
More informationHRCT Versus Volume Rendering (Three Colors, Three Densities Lung Images) in Diagnosis of Small Airway Disease: A Comparative Study
Med. J. Cairo Univ., Vol. 84, No. 1, March: 359-364, 2016 www.medicaljournalofcairouniversity.net HRCT Versus Volume Rendering (Three Colors, Three Densities Lung Images) in Diagnosis of Small Airway Disease:
More informationTBLB is not recommended as the initial biopsy option in cases of suspected IPF and is unreliable in the diagnosis of rare lung disease (other than
TBLB is not recommended as the initial biopsy option in cases of suspected IPF and is unreliable in the diagnosis of rare lung disease (other than PAP) BAL is not required as a diagnostic tool in patients
More informationChest X-ray Interpretation
Chest X-ray Interpretation Introduction Routinely obtained Pulmonary specialist consultation Inherent physical exam limitations Chest x-ray limitations Physical exam and chest x-ray provide compliment
More informationChest XRay interpretation INTERPRETATIONS Identifications: Name & Date Technical evaluation Basic Interpretations
Chest XRay interpretation INTERPRETATIONS Identifications: Name & Date Technical evaluation Basic Interpretations TECHNICAL EVALUATION 1. Projection: AP/PA view To differentiate between AP & PA films,
More informationCT Findings in Pediatric Novel Influenza A (H1N1)-Associated Pneumonia
Original Article Iran J Pediatr Jun 2012; Vol 22 (No 2), Pp: 213-217 CT Findings in Pediatric Novel Influenza A (H1N1)-Associated Pneumonia Takashi Yoshinobu 1, MD; Katsumi Abe* 1, MD, PhD; Hisashi Shimizu
More informationImaging Cancer Treatment Complications in the Chest
Imaging Cancer Treatment Complications in the Chest Michelle S. Ginsberg, MD Objectives Imaging Cancer Treatment Complications in the Chest To understand the mechanisms of action of different classes of
More informationDiagnostic challenges in IPF
Medicine, Nursing and Health Sciences Diagnostic challenges in IPF Dr Ian Glaspole Central and Eastern Clinical School, Alfred Hospital and Monash University March 2015 Disclosures Consultancy fees from
More informationUsual Interstitial Pneumonia and Non-Specific Interstitial Pneumonia: Serial Thin-Section CT Findings Correlated with Pulmonary Function
Usual Interstitial Pneumonia and Non-Specific Interstitial Pneumonia: Serial Thin-Section CT Findings Correlated with Pulmonary Function Yeon Joo Jeong, MD 1, 2 Kyung Soo Lee, MD 1 Nestor L. Muller, MD
More informationDiffuse interstitial lung diseases (DILDs) are a heterogeneous group of non-neoplastic, noninfectious
Focused Issue of This Month Diagnostic Approaches to Diffuse Interstitial Lung Diseases Dong Soon Kim, MD Department of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine E -
More informationARDS - a must know. Page 1 of 14
ARDS - a must know Poster No.: C-1683 Congress: ECR 2016 Type: Authors: Keywords: DOI: Educational Exhibit M. Cristian; Turda/RO Education and training, Edema, Acute, Localisation, Education, Digital radiography,
More informationCase Presentations in ILD. Harold R. Collard, MD Department of Medicine University of California San Francisco
Case Presentations in ILD Harold R. Collard, MD Department of Medicine University of California San Francisco Outline Overview of diagnosis in ILD Definition/Classification High-resolution CT scan Multidisciplinary
More informationImaging findings in Hypersensitivity Pneumonitis - a pictorical review.
Imaging findings in Hypersensitivity Pneumonitis - a pictorical review. Poster No.: C-1655 Congress: ECR 2014 Type: Educational Exhibit Authors: B. M. Araujo, A. F. S. Simões, M. S. C. Rodrigues, J. Pereira;
More informationIdiopathic Pulmonary of Care
Chapter 6.1 Living Medical etextbook A Digital Tool at the Point of Care From Projects In Knowledge Pulmonology Idiopathic Pulmonary Fibrosis @Point of Care IPF Case Study: Typical Presentation, Role of
More informationCase of the Day Chest
Case of the Day Chest Darin White MDCM FRCPC Department of Radiology, Mayo Clinic 76 th Annual Scientific Meeting Canadian Association of Radiologists Montreal, QC April 26, 2013 2013 MFMER slide-1 Disclosures
More informationHow to identify interstitial pneumonias.
How to identify interstitial pneumonias. Poster No.: C-0804 Congress: ECR 2014 Type: Educational Exhibit Authors: S. claret loaiza, M. C. Cañete Moslero, R. Carreño Gonzalez, C. de la Torre; Malaga/ES
More informationThe crazy-paving pattern: A radiological-pathological correlated and illustrated overview
The crazy-paving pattern: A radiological-pathological correlated and illustrated overview Poster No.: C-0827 Congress: ECR 2010 Type: Educational Exhibit Topic: Chest Authors: W. F. M. De Wever, J. Coolen,
More informationManish Powari Regional Training Day 10/12/2014
Manish Powari Regional Training Day 10/12/2014 Large number of different types of Interstitial Lung Disease (ILD). Most are very rare Most patients present with one of a smaller number of commoner diseases
More informationDIAGNOSTIC NOTE TEMPLATE
DIAGNOSTIC NOTE TEMPLATE SOAP NOTE TEMPLATE WHEN CONSIDERING A DIAGNOSIS OF IDIOPATHIC PULMONARY FIBROSIS (IPF) CHIEF COMPLAINT HISTORY OF PRESENT ILLNESS Consider IPF as possible diagnosis if any of the
More informationRadiologic pathologic discordance in biopsy-proven usual interstitial pneumonia
ERJ Express. Published on February 25, 2016 as doi: 10.1183/13993003.01680-2015 ORIGINAL ARTICLE IN PRESS CORRECTED PROOF Radiologic pathologic discordance in biopsy-proven usual interstitial pneumonia
More informationHYPERSENSITIVITY PNEUMONITIS
HYPERSENSITIVITY PNEUMONITIS A preventable fibrosis MOSAVIR ANSARIE MB., FCCP INTERSTITIAL LUNG DISEASES A heterogeneous group of non infectious, non malignant diffuse parenchymal disorders of the lower
More informationSmoking-related Interstitial Lung Diseases: High-Resolution CT Findings
Smoking-related Interstitial Lung Diseases: High-Resolution CT Findings Poster No.: C-2358 Congress: ECR 2013 Type: Educational Exhibit Authors: V. Cuartero Revilla, M. Nogueras Carrasco, P. Olmedilla
More informationChildren are not small adults Children are Not Small Adults Anatomic considerations Pliable bony & cartilagenous structures - Significant thoracic inj
PEDIATRIC CHEST TRAUMA Children are not small adults Role of imaging Spectrum of injury Children are not small adults Children are Not Small Adults Anatomic considerations Pliable bony & cartilagenous
More information2009 H1N1 Influenza Infection: Spectrum Of Chest CT Findings, With Radiologic- Pathologic Correlation
ISPUB.COM The Internet Journal of Radiology Volume 12 Number 2 2009 H1N1 Influenza Infection: Spectrum Of Chest CT Findings, With Radiologic- Pathologic Correlation A Nachiappan, E Weihe, B Akkanti, V
More informationInternational consensus statement on idiopathic pulmonary fibrosis
Eur Respir J 2001; 17: 163 167 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2001 European Respiratory Journal ISSN 0903-1936 PERSPECTIVE International consensus statement on idiopathic
More informationOBJECTIVES. Solitary Solid Spiculated Nodule. What would you do next? Case Based Discussion: State of the Art Management of Lung Nodules.
Organ Imaging : September 25 2015 OBJECTIVES Case Based Discussion: State of the Art Management of Lung Nodules Dr. Elsie T. Nguyen Dr. Kazuhiro Yasufuku 1. To review guidelines for follow up and management
More informationImaging Small Airways Diseases: Not Just Air trapping. Eric J. Stern MD University of Washington
Imaging Small Airways Diseases: Not Just Air trapping Eric J. Stern MD University of Washington What we are discussing SAD classification SAD imaging with MDCT emphasis What is a small airway? Airway with
More informationThin-Section CT Findings of Arc-Welders Pneumoconiosis
Thin-Section CT Findings of Arc-Welders Pneumoconiosis Daehee Han, MD 1 Jin Mo Goo, MD 1 Jung-Gi Im, MD 1 Kyung Soo Lee, MD 2 Do Myung Paek, MD 3 Seong Ho Park, MD 1 Index words: Lungs, diseases Lungs,
More informationSCLERODERMA LUNG DISEASE: WHAT THE PATIENT SHOULD KNOW
SCLERODERMA LUNG DISEASE: WHAT THE PATIENT SHOULD KNOW Lung disease can be a serious complication of scleroderma. The two most common types of lung disease in patients with scleroderma are interstitial
More informationThoracic CT pattern in lung cancer: correlation of CT and pathologic diagnosis
19 th Congress of APSR PG of Lung Cancer (ESAP): Update of Lung Cancer Thoracic CT pattern in lung cancer: correlation of CT and pathologic diagnosis Kazuma Kishi, M.D. Department of Respiratory Medicine,
More informationThe Imaging Analysis of Pulmonary Sarcodiosis
www.cancercellresearch.org ISSN: 2161-2609 Article The Imaging Analysis of Pulmonary Sarcodiosis Xin He, Chuanyu Zhang* Department of Radiology, Affiliated Hospital of Qingdao University, Qingdao, China
More informationAsbestosis and other pulmonary fibrosis in asbestos-exposed workers: high-resolution CT features with pathological correlations
Eur Radiol (2016) 26:1485 1492 DOI 10.1007/s00330-015-3973-z CHEST Asbestosis and other pulmonary fibrosis in asbestos-exposed workers: high-resolution CT features with pathological correlations Hiroaki
More informationAfter the Chest X-Ray:
After the Chest X-Ray: What To Do Next Alan S. Brody Professor of Radiology and Pediatrics Chief of Thoracic Imaging Cincinnati Children s Hospital Cincinnati, Ohio USA What Should We Do Next? CT scan?
More informationAn Introduction to Radiology for TB Nurses
An Introduction to Radiology for TB Nurses Garold O. Minns, MD September 14, 2017 TB Nurse Case Management September 12 14, 2017 EXCELLENCE EXPERTISE INNOVATION Garold O. Minns, MD has the following disclosures
More informationCase 1: Question. 1.1 What is the main pattern of this HRCT? 1. Intralobular line 2. Groundglass opacity 3. Perilymphatic nodule
HRCT WORK SHOP Case 1 Case 1: Question 1.1 What is the main pattern of this HRCT? 1. Intralobular line 2. Groundglass opacity 3. Perilymphatic nodule Case 1: Question 1.2 What is the diagnosis? 1. Hypersensitivity
More informationRadiation Exposure in Pregnancy. John R. Mayo UNIVERSITY OF BRITISH COLUMBIA
Radiation Exposure in Pregnancy John R. Mayo UNIVERSITY OF BRITISH COLUMBIA Illustrative Clinical Scenario 32 year old female 34 weeks pregnant with recent onset shortness of breath and central chest pain
More informationRestrictive Pulmonary Diseases
Restrictive Pulmonary Diseases Causes: Acute alveolo-capillary sysfunction Interstitial disease Pleural disorders Chest wall disorders Neuromuscular disease Resistance Pathophysiology Reduced compliance
More informationLangerhans Cell Histiocytosis with Anterior Mediastinum, Pulmonary and Liver Involvement: CT Demonstration
Chin J Radiol 2002; 27: 191-195 191 Langerhans Cell Histiocytosis with Anterior Mediastinum, Pulmonary and Liver Involvement: CT Demonstration SIU-CHEUNG CHAN 1 MUN-CHING WONG 1 SHIU-FENG HUANG 2 WAN-CHAK
More informationLow-dose CT Lung Cancer Screening Guidelines for Pulmonary Nodules Management Version 2
Low-dose CT Lung Cancer Screening Guidelines for Pulmonary Nodules Management Version 2 The Committee for Management of CT-screening-detected Pulmonary Nodules 2009-2011 The Japanese Society of CT Screening
More informationSESSION IV: MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS PULMONARY PATHOLOGY I. December 5, 2012
SESSION IV: MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS PULMONARY PATHOLOGY I December 5, 2012 FACULTY COPY GOAL: Describe the basic morphologic and pathophysiologic changes in various conditions
More informationFollicular bronchiolitis in surgical lung biopsies: Clinical implications in 12 patients
Respiratory Medicine (2008) 102, 307 312 Follicular bronchiolitis in surgical lung biopsies: Clinical implications in 12 patients Michelle R. Aerni a, Robert Vassallo a,, Jeffrey L. Myers b, Rebecca M.
More informationACUTE RESPIRATORY DISTRESS SYNDROME
ACUTE RESPIRATORY DISTRESS SYNDROME Angel Coz MD, FCCP, DCE Assistant Professor of Medicine UCSF Fresno November 4, 2017 No disclosures OBJECTIVES Identify current trends and risk factors of ARDS Describe
More informationCase 1 : Question. 1.1 What is the intralobular distribution? 1. Centrilobular 2. Perilymphatic 3. Random
Interesting case Case 1 Case 1 : Question 1.1 What is the intralobular distribution? 1. Centrilobular 2. Perilymphatic 3. Random Case 1: Answer 1.1 What is the intralobular distribution? 1. Centrilobular
More informationComparison of CT findings between MDR-TB and XDR-TB
Comparison of CT findings between MDR-TB and XDR-TB Poster No.: C-0757 Congress: ECR 2017 Type: Authors: Keywords: DOI: Scientific Exhibit K. Yoon, H. Soohee; Changwon-si/KR Thorax, Lung, Respiratory system,
More information10/17/2016. Nuts and Bolts of Thoracic Radiology. Objectives. Techniques
Nuts and Bolts of Thoracic Radiology October 20, 2016 Carleen Risaliti Objectives Understand the basics of chest radiograph Develop a system for interpreting chest radiographs Correctly identify thoracic
More informationCLEARING THE AIR ON DIFFUSE PARENCHYMAL (INTERSTITIAL) LUNG DISEASE (ILD)
CLEARING THE AIR ON DIFFUSE PARENCHYMAL (INTERSTITIAL) LUNG DISEASE (ILD) David Northrop MBA, RRT Assistant Director of Respiratory Therapy Services The University of Kansas Health System Clinical Assistant
More informationIPF: Epidemiologia e stato dell arte
IPF: Epidemiologia e stato dell arte Clinical Classification Diffuse parenchimal lung diseases Exposure-related: - occupational - environmental - medication Desquamative interstitial pneumonia Idiopathic
More informationAcute Exacerbation of Usual Interstitial Pneumonia After Resection of Lung Cancer
Acute Exacerbation of Usual Interstitial Pneumonia After Resection of Lung Cancer Hiroaki Sugiura, MD, Atsuya Takeda, MD, PhD, Toshiko Hoshi, MD, PhD, Yoshinori Kawabata, MD, Koichi Sayama, MD, PhD, Masahiro
More informationBronkhorst colloquium Interstitiële longziekten. Katrien Grünberg, klinisch patholoog
Bronkhorst colloquium 2013-2014 Interstitiële longziekten De pathologie achter de CT Katrien Grünberg, klinisch patholoog K.grunberg@vumc.nl Preparing: introduction and 3 cases The introduction on microscopic
More informationPostmortem Computed Tomography Finding of Lungs in Sudden Infant Death.
Postmortem Computed Tomography Finding of Lungs in Sudden Infant Death. Poster No.: C-1147 Congress: ECR 2013 Type: Educational Exhibit Authors: Y. Kawasumi, A. Usui, Y. Hosokai, M. Sato, A. Nakajima,
More informationA Review of Interstitial Lung Diseases
Outline A Review of Interstitial Lung Diseases Paul J. Wolters, MD Associate Professor Department of Medicine University of California San Francisco Overview of diagnosis in ILD Why it is important Definition/Classification
More informationLung Allograft Dysfunction
Lung Allograft Dysfunction Carlos S. Restrepo M.D. Ameya Baxi M.D. Department of Radiology University of Texas Health San Antonio Disclaimer: We do not have any conflict of interest or financial gain to
More informationCommon things are common, but not always the answer
Kevin Conroy, Joe Mackenzie, Stephen Cowie kevin.conroy@nhs.net Respiratory Dept, Darlington Memorial Hospital, Darlington, UK. Common things are common, but not always the answer Case report Cite as:
More informationI have no relevant conflicts of interest to disclose
I have no relevant conflicts of interest to disclose Diffuse parenchymal lung disease (DPLD) and its associations Secondary lobular anatomy DPLD History, clinical findings, temporal evolution, and exposures
More information